期刊文献+

丹酚酸C在大鼠体内的代谢产物 被引量:3

Metabolites of salvianolic acid C in rats in vivo
下载PDF
导出
摘要 分离鉴定大鼠灌胃丹酚酸C后血浆和尿液中的代谢产物。代谢样品用强阴离子交换小柱固相萃取方法进行制备后,采用高效液相-四极杆-飞行时间串联质谱(HPLC-ESI/Q-TOF MS/MS),在负离子模式下进行检测,获取数据进行结构鉴定。从大鼠血浆和尿液中检测到丹酚酸C原形成分和5个代谢产物,分别鉴定为caffeic acid(M1),monomethyl-salvianolic acid C-monoglucuronide(M2),dimethyl-salvianolic acid C-monoglucuronide(M3),dimethyl-salvianolic acid Cmonoglucuronide(M4),dimethyl-salvianolic acid C(M5)。结果表明丹酚酸C在大鼠体内的主要代谢途径是甲基化和葡萄糖醛酸化反应。 The objective of this study was to separate and identify the metabolites in rat plasma and urine after oral administration of salvianolic acid C, a phenolic acid in Salvia miltiorrhiza(Danshen). Solid-phase extraction method with strong anion exchange was used to separate the metabolites from the biological matrix. High-performance liquid chromatography coupled with electrospray quadrupole time-of-flight tandem mass spectrometry(HPLC-ESI/Q-TOF MS/MS)analysis was performed to identify the metabolites. Five metabolites were identified as caffeic acid(M1), monomethyl-salvianolic acid C-monoglucuronide(M2), dimethyl-salvianolic acid C-monoglucuronide(M3), dimethyl-salvianolic acid C-monoglucuronide(M4), dimethyl-salvianolic acid C(M5), as well as the prototype of salvianolic acid C detected in plasma and urine. The results indicated that methylation and glucuronidation might be the two main metabolic pathways of salvianolic acid C.
出处 《中国药科大学学报》 CAS CSCD 北大核心 2013年第5期442-446,共5页 Journal of China Pharmaceutical University
基金 国家科技支撑计划资助项目(No.2008BAI51B01) 国家自然科学基金资助项目(No.81073006)~~
关键词 丹酚酸C 代谢产物 大鼠 HPLC—ESI Q—TOF MS MS salvianolic acid C metabolites rats HPLC-ESI/Q-TOF MS/MS
  • 相关文献

参考文献9

  • 1陈峰,李泽友,刘明生.丹参制剂的研究进展[J].中国药房,2006,17(21):1675-1677. 被引量:12
  • 2Zhang Y, Akao T, Nakamura N,et al. Magnesium lithospermate B is excreted rapidly into rat bile mostly as methylated metabolites, which are potent antioxidants [ J ]. Drug Metab Dispos, 2004,32 (7) :752 -757.
  • 3Cui L, Chan W,Wu JL,et al. High performance liquid chromatog- raph,-mass spectrometry analysis for rat metabolism and pharma- cokinetic studies of lithospermic acid B from danshen[ J]. Talan- ta,2008,75 (4) : 1 002 - 1 007.
  • 4Shen Y, Wang XY, Xu LH,et al. Characterization of metabolites inrat plasma after intravenous administration of salvianolic acid A by liquid chromatography/time-of-flight mass spectrometry and liquid chromatography/ion trap mass spectrometry [ J ]. Rapid Commun Mass Spectrom, 2009,23 ( 12 ) : 1 810 - 1 816.
  • 5Nakazawa T, Ohsawa K. Metabolism of rosmarinic acid in rats [ J ]. J Nat Prod, 1998,61 ( 8 ) :993 - 996.
  • 6Zhang YF, SHI PY, Yao H ,et al. Metabolite profiling and pharma- cokinetics of herbal compounds following oral administration of a cardiovascular muhi-herb medicine ( Qishen yiqi pills) in rat [ J ]. Curr Drug Metab ,2013 ,13( 5 ) :510 -523.
  • 7Xu JZ,Zeng SS,Chen XY ,et al. Isolation and identification of deg- radation products of salvianolic acid A by NMR and LC-MS [ J ]. Fitoterapia,2011,82 ( 2 ) :260 - 266.
  • 8Redeuil K,Smarrito-Menozzi C,et al. Identification of novel circu- lating coffee metabolites in human plasma by liquid chromatogra- phy-mass spectrometry[ J ]. J Chromatogr A, 2011,1 218 ( 29 ) : 4 678-4 688.
  • 9Li X, Xu X, Wang J, et al. A system-level investigation into the mechanisms of Chinese traditional medicine : compound Danshen formula for cardiovascular disease treatment [ J ]. PLoS One,2012, 7(9) :e4-3918.

二级参考文献12

共引文献11

同被引文献31

  • 1彭晖,余学清,娄探奇,方芳,周飞宇,尹培达.人血清白蛋白对近端肾小管上皮细胞骨调素和CD44表达的影响[J].中国病理生理杂志,2005,21(5):911-914. 被引量:2
  • 2王立,金哲雄.平榛鞣质成分研究(Ⅲ)(英文)[J].中草药,2006,37(6):810-812. 被引量:4
  • 3Cooper EH, Bedford AJ, Kenny TE. Cell death in normal and malignant tissues[ Jl. Adv Cancer Res, 1975,2I :59 - 120.
  • 4Smith BA, Smith BD. Biomarkers and molecular probes for cell death imaging and targeted therapeutics [ J ]. Bioconjug Chem, 2012,23 ( 10) : 1989 - 2006.
  • 5Chen SL, Yu LK, Jiang CY, et al. Pivotal study of iodine-131- labeled chimeric tumor necrosis treatment radioimmunotherapy in patients with advanced lung cancer [ J ]. J Clin 0ncol,2005,23 (7) :1538 - 1547.
  • 6Li J, Oyen R, Verbruggen A, et al. Small molecule sequential dual-targeting theragnostiestrategy ( SMSDTFS ) : from preelinieal experiments towards possible clinical antieaneer applications [ J]. J Cancer,2013,4(2 ) : 133 - 145.
  • 7Van de Putte M, Marysael T, Fonge H, et al. Radiolabelediodohy- pericin as tumor necrosis avid tracer: diagnostic and therapeutic potential[ J]. Int J Cancer,2012,131 (2) :E129 -E137.
  • 8Kerb R, Brockmller J, Staffeldt B, et al. Single-dose and steady- state pharmacokinetics of hypericin and pseudohypericin [ J ]. Antimicrob Agents Chemother, 1996,40 (9) : 2087 - 2093.
  • 9Kamuhabwa AAR, Di Mavungu JD, Baert L, et al. Determination of hypericin in human plasma by high-performance liquid chro- matography after intravesical administration in patients with tran- sitional cell carcinoma of the bladder [ J . Eur J Pharm Biop- harm,2005,59 (3) :469 - 474.
  • 10Kong M, Zhang J, Jiang CH, et aL Necrosis affinity evaluation of 1311-hyperiein in a rat model of induced necrosis [ J ]. J Drug Target ,2013,21 ( 6 ) :604 - 610.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部